| 1 |
Rapamycin as a potent and selective inhibitor of vascular endothelial growth factor receptor in breast carcinoma |
|
| | Muhammad Shahidan Muhammad Sakri, Tengku Ahmad Damitri Al-Astani Tengku Din, Hasnan Jaafar, Vinod Gopalan, Wan Faiziah Wan Abdul Rahman | | | International Journal of Immunopathology and Pharmacology. 2022; 36: 2058738421 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
From Editor's desk |
|
| | Ranjan Agrawal | | | Indian Journal of Pathology and Microbiology. 2020; 63(5): 1 | | | [Pubmed] [Google Scholar] [DOI] | |
|
